SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health response to COVID-19. The emergence of hypermutated, increasingly transmissible variants of concern (VOCs) threaten this strategy. Omicron (B.1.1.529), the fifth VOC to be described, harbours multiple amino acid...

Descripción completa

Detalles Bibliográficos
Autores principales: Willett, BJ, Grove, J, MacLean, OA, Klenerman, P, Dunachie, S, Barnes, E, Brown, A, Adele, S, Kronsteiner, B, Murray, SM, Abraham, P, Deeks, A, Ansari, MA, Fraser, C, Bonsall, D, Fryer, H, Lythgoe, K, Thomson, L, Golubchik, T, Underwood, AP, Taylor, BEW, Yeats, CA, Aanensen, DM, Abudahab, K, Menegazzo, M, Zarebski, AE, Gutierrez, B, Raghwani, J, du Plessis, L, Kraemer, MUG, Pybus, OG, Francois, S, Attwood, SW, Vasylyeva, TI, Trebes, A, Green, A, Buck, D, MacIntyre-Cockett, G, Todd, JA
Otros Autores: PITCH Consortium
Formato: Journal article
Lenguaje:English
Publicado: Springer Nature 2022
Materias:
molecular biology
immunology
vaccines
viral infection

Ejemplares similares